Zhejiang Jingxin Pharmaceutical Co., Ltd. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Jingxin Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Xiamen Kingdomway Group Co
sales of 1.66 billion Chinese Renmimbi [US$262.63 million]
of which 99%
Yabao Pharmaceutical Group Company Limited
(1.81 billion Chinese Renmimbi [US$285.26 million]
of which 73%
was Pharrmaceutical Manufacturing), and
PKU HealthCare Corp Ltd
(2.07 billion Chinese Renmimbi [US$326.94 million]
of which 86%
was Merchandise&Material Selling).
Zhejiang Jingxin Pharmaceutical Co., Ltd. reported sales of 1.87 billion Chinese Renmimbi (US$296.13 million)
December of 2016.
increase of 32.5%
versus 2015, when the company's sales were 1.41 billion Chinese Renmimbi.
Sales at Zhejiang Jingxin Pharmaceutical Co., Ltd. have increased during each of the previous five years
(and since 2011, sales have increased a total of 164%).
Sales of Medical Display saw an increase
that was more than double the company's growth rate: sales were up
655.1% in 2016, from
47.44 million Chinese Renmimbi to 358.22 million Chinese Renmimbi.
Zhejiang Jingxin Pharmaceutical Co., Ltd. also saw significant increases in sales in
Other (up 50.1% to 48.49 million Chinese Renmimbi)